Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 13/20 | 0.46 |
| ▸ | TP53 | P04637 | 7/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.35 |
| ▸ | HTR3A | P46098 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14848749 | 0.84 | CYP2A6 (0.56) | CYP2A6MAPTTP53CA2THRB | |
| SCHEMBL424317 | 0.82 | CYP2A6 (0.48) | CYP2A6MAPTTP53CA2THRB | |
| SCHEMBL7541080 | 0.80 | MAPT (0.45) | CYP2A6MAPTTP53CA2THRB | |
| SCHEMBL6608239 | 0.80 | MAPT (0.46) | CYP2A6MAPTTP53CA2THRB | |
| SCHEMBL17140096 | 0.78 | MAPT (0.44) | CYP2A6MAPTTP53CA2THRB | |
| SCHEMBL19099909 | 0.78 | MAPT (0.44) | CYP2A6MAPTTP53CA2THRB | |
| SCHEMBL422138 | 0.78 | CYP2A6 (0.50) | CYP2A6MAPTTP53CA2THRB | |
| SCHEMBL8147097 | 0.78 | CA2 (0.47) | CYP2A6MAPTTP53CA2THRB | |
| SCHEMBL788066 | 0.78 | CYP2A6 (0.60) | CYP2A6MAPTTP53CA2LMNA | |
| SCHEMBL5335374 | 0.78 | CYP2A6 (0.60) | CYP2A6MAPTCA2THRBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 200 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3339302-A1 | PYRIDINE DERIVATIVE | Teijin Pharma Limited (JP) | 2018-06-27 | — | — | EP | claimed |
| US-20170190694-A1 | PYRIDINE DERIVATIVE | TEIJIN PHARMA LIMITED (JP) | 2017-07-06 | — | — | US | claimed |
| EP-2944633-A1 | PYRIDINE DERIVATIVE | Teijin Pharma Limited (JP) | 2015-11-18 | — | — | EP | claimed |
| US-12043749-B2 | Method for producing ink composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-07-23 | — | — | US | disclosed |
| US-12043749-B2 | Method for producing ink composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-07-23 | — | — | US | disclosed |
| US-11917839-B2 | High signal-to-noise ratio photoelectric conversion element | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-02-27 | — | — | US | disclosed |
| US-11917839-B2 | High signal-to-noise ratio photoelectric conversion element | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-02-27 | — | — | US | disclosed |
| US-20240023422-A1 | COMPOSITION, FILM, ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, AND PHOTODETECTION ELEMENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-01-18 | — | — | US | disclosed |
| US-20240023422-A1 | COMPOSITION, FILM, ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, AND PHOTODETECTION ELEMENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-01-18 | — | — | US | disclosed |
| US-11877459-B2 | Light detecting element | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-01-16 | — | — | US | disclosed |
| US-11877459-B2 | Light detecting element | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-01-16 | — | — | US | disclosed |
| US-7230020-B2 | 11β-hydroxysteroid dehydrogenase inhibitors | STERIX LIMITED (GB) | 2007-06-12 | — | — | US | disclosed |
| US-20070077506-A1 | Electrophotographic photoreceptor and image forming apparatus provided with the same | SHARP KABUSHIKI KAISHA (JP) | 2007-04-05 | — | — | US | disclosed |
| US-20070077506-A1 | Electrophotographic photoreceptor and image forming apparatus provided with the same | SHARP KABUSHIKI KAISHA (JP) | 2007-04-05 | — | — | US | disclosed |
| US-7175956-B2 | Organic photoconductive material, electrophotographic photoreceptor comprising the same, and image-forming apparatus | SHARP KABUSHIKI KAISHA (JP) | 2007-02-13 | — | — | US | disclosed |
| US-7175956-B2 | Organic photoconductive material, electrophotographic photoreceptor comprising the same, and image-forming apparatus | SHARP KABUSHIKI KAISHA (JP) | 2007-02-13 | — | — | US | disclosed |
| US-20070026334-A1 | Electrophotographic photoreceptor and image forming apparatus including the same | SHARP KABUSHIKI KAISHA (JP) | 2007-02-01 | — | — | US | disclosed |
| US-20070026334-A1 | Electrophotographic photoreceptor and image forming apparatus including the same | SHARP KABUSHIKI KAISHA (JP) | 2007-02-01 | — | — | US | disclosed |
| US-20030073832-A1 | Novel aminophenyl ketone derivatives | LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) | 2003-04-17 | — | — | US | disclosed |
| WO-2002083622-A2 | NOVEL AMINOPHENYL KETONE DERIVATIVES | LEO PHARMA A/S (DK) | 2002-10-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030073832-A1 | Novel aminophenyl ketone derivatives | MAPKAPK2, MAP3K2, MAP3K1 | CYP2A6 1648/4885MAPT 1188/4885TP53 3231/4885 |
| US-20170190694-A1 | PYRIDINE DERIVATIVE | HPRT1, XDH, NUDT1 | CYP2A6 1634/4885MAPT 451/4885TP53 3221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.